Tag: Stemetil

Prochlorperazine, the active ingredient in Stemetil, is known to cause a range of extrapyramidal symptoms, including dystonia. The question, **Can Stemetil cause dystonia?**, is a crucial one, as this adverse reaction can involve painful, involuntary muscle contractions that can be frightening for patients.

First approved for medical use in the United States in 1956, the medication known by the brand name Stemetil contains the active ingredient prochlorperazine. So, what class of drug is Stemetil? It belongs to the phenothiazine class, a group of drugs with both antiemetic (anti-sickness) and antipsychotic properties.

While prochlorperazine, the active ingredient in Stemetil, has been a treatment for nausea for decades, its availability has become complex. Contrary to a total withdrawal, the question 'Why has Stemetil been taken off the market?' points to specific product discontinuations, not a complete ban [1.2.1, 1.2.7].

Studies have found that taking multiple medications with anticholinergic properties can significantly increase the risk of cognitive and functional impairment [1.7.1]. This raises the important question: can you take Stemetil with amitriptyline, two drugs with such properties?

Combining Stemetil (prochlorperazine) and propranolol can cause additive effects in lowering blood pressure, which may increase the risk of dizziness, lightheadedness, and fainting. It is crucial to consult a doctor before taking these medications together to manage potential interactions effectively.

According to Mayo Clinic, the active ingredient in Stemetil, prochlorperazine, can cause various side effects, including serious movement disorders with long-term or high-dose use. This guide explores **what are the side effects of taking Stemetil?**, outlining both common and rare adverse reactions to help you understand the risks and precautions associated with this medication.

In a significant safety measure, batches of Stemetil 5mg/5ml syrup were recalled in 2022 by manufacturer Sanofi due to the presence of a probable human carcinogen, explaining the discontinuation of this specific formulation. This action was triggered after laboratory tests identified levels of N-nitrosomethylphenylamine (NMPA) above the acceptable safety limit.

While Stemetil (prochlorperazine) is an effective treatment for severe nausea and vertigo, its status as a first-generation antipsychotic means it carries significant risks not shared by newer alternatives. Understanding the full spectrum of what is the problem with Stemetil, including its neurological and cardiovascular risks, is critical for both patients and healthcare providers.

While some studies indicate that prochlorperazine (Stemetil) can have an anxiolytic effect, it is not considered a first-choice medication for anxiety due to its potential for serious side effects. Primarily known for treating nausea, vomiting, and certain psychotic disorders, its use for anxiety is limited to specific, short-term situations. It is crucial to understand its mechanism and compare it with standard anxiety treatments to make an informed decision.

According to prescribing information, daily limits for Stemetil vary depending on the condition being treated. Knowing the appropriate limits of Stemetil (prochlorperazine) is crucial for avoiding potential side effects and ensuring effective treatment for conditions such as severe nausea, vertigo, and certain psychological disorders.